Literature DB >> 6426691

Neuroleptic malignant syndrome.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6426691      PMCID： PMC1441455          DOI： 10.1136/bmj.288.6431.1690-b

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  6 in total

1.  Neuroleptic malignant syndrome. Successful treatment with bromocriptine.

Authors:  P S Mueller; J W Vester; J Fermaglich
Journal:  JAMA       Date:  1983-01-21       Impact factor: 56.272

2.  The neuroleptic malignant syndrome.

Authors:  R A Smego; D T Durack
Journal:  Arch Intern Med       Date:  1982-06

3.  A case of neuroleptic malignant syndrome successfully treated with amantadine.

Authors:  M M McCarron; M L Boettger; J J Peck
Journal:  J Clin Psychiatry       Date:  1982-09       Impact factor: 4.384

4.  ECT in the neuroleptic malignant syndrome: case report.

Authors:  S S Jessee; G F Anderson
Journal:  J Clin Psychiatry       Date:  1983-05       Impact factor: 4.384

5.  Management of a case of neuroleptic malignant syndrome with bromocriptine.

Authors:  G Zubenko; H G Pope
Journal:  Am J Psychiatry       Date:  1983-12       Impact factor: 18.112

6.  The neuroleptic malignant syndrome.

Authors:  S N Caroff
Journal:  J Clin Psychiatry       Date:  1980-03       Impact factor: 4.384
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.